BioSpace News Archive

A new Series B financing round sees Peter Thiel, co-founder of PayPal and Palantir Technologies, joining entrepreneur Christian Angermayer in investing $35 million in Pittsburgh, Penn.-based biotech Peptilogics.

Dr. Reddy’s Laboratories Ltd., Appili Therapeutics and Global Response Aid FZCO announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ Tablets for the acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

Phase I safety, tolerability, and pharmacokinetic study in healthy volunteers expected to start in coming weeks following acceptance of a request for a Clinical Trial Authorization (CTA) granted by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Hutchison China MediTech Limited announces that Christian Hogg, Chief Executive Officer, will present at the 39th Annual JP Morgan Healthcare Conference taking place virtually on Monday January 11, 2021 at 8 a.m. EST.

Amgen and AstraZeneca announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid dose, without loss of asthma control, with tezepelumab compared to placebo.

Ultimovacs ASA, announced the initiation of FOCUS, a Phase II randomized clinical trial that will evaluate the Company’s proprietary universal cancer vaccine, UV1, in 75 patients with recurrent or metastatic head and neck cancer who will be treated with standard of care therapy pembrolizumab.

Program focused on identifying small molecules that target a GPCR for degradation as potential therapeutic agents for gastrointestinal disorders

LSBio, a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast.

Cold Spring Harbor Laboratory scientists have discovered a gene-regulating snippet of RNA that may contribute to the spread of many breast cancers.

Marken announced the launch of two new facilities in Kiev, Ukraine and in Los Angeles, United States.